PLAU and cervical carcinoma: Furthermore, cervical cancer patients with increased expression of EGFR (P=0.023, Figure 2B), uPA (P=0.0005, Figure 2C), or TM (P=0.059, Figure 2D) had decreased overall survival compared to the patients with normal levels.